Skip to content

Comparative Study of Two Embryo Culture Systems

Comparative Study of Two Embryo Culture Systems: Randomization of Attempts at In Vitro Fertilization With ICSI at the Centre for Medically Assisted Procreation at Dijon CHU

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02722252
Acronym
INCUBATE
Enrollment
388
Registered
2016-03-29
Start date
2014-08-27
Completion date
2017-03-29
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

In Vitro Fertilization with ICSI

Brief summary

The centre for Medically-Assisted Procreation (MAP) of Dijon CHU has two high-technology embryo culture systems, with incubation characteristics that are potentially superior to those provided by classical culture systems. Indeed, these two systems, available in only two MAP centres in France, make it possible to maintain a stable temperature and gaseous environment during the in-vitro development of the embryos. It is necessary to observe the development of the embryos to determine which embryos have the highest implantation potential. These observations are done from time to time by microscope for one system and continuously using an incorporated video camera for the other (cinematographic study). The MAP centre in Dijon wishes to compare the interest of these two systems.

Interventions

DEVICEEmbryo culture system without incorporated camera

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Persons who have provided oral consent * Attempt at In Vitro Fertilization with ICSI (IntraCytoplasmic Sperm Injection) * At least 6 mature ovocytes to microinject

Exclusion criteria

* Persons not covered by national health insurance * Attempt at In Vitro Fertilization (IVF) * Fewer than 6 mature ovocytes * Decision to transfer at the zygote stage during the multidisciplinary meeting * Attempts made in a context of viral risk (both systems are in a virus risk-free zone) * Attempts with surgically-harvested spermatozoa

Design outcomes

Primary

MeasureTime frameDescription
Implantation rate16 weeks after transferThe implantation rate is defined as the number of embryos implanted (gestational sacs seen on the US scan) compared to the total number of embryos transferred.

Secondary

MeasureTime frame
Rate of miscarriages16 weeks after transfer

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026